Objective To determine whether pretreatment evaluation with contrast-enhanced
ultrasonography (CEUS) is effective for percutaneous radiofrequency ablation (RFA) of …

Radiofrequency ablation (RFA) has become mainstream among non-surgical treatment
modalities in clinical settings for the treatment of hepatocellular carcinoma. We have …

Objective To evaluate the clinical value of contrast-enhanced ultrasound (CEUS) in
selection of the patients with hepatocellular carcinoma (HCC) indicated to radiofrequency …

BACKGROUND Neoplastic seeding reportedly occurs in up to 12.5% of patients treated with
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). The aim of this study is …

Background Nodules of hepatocellular carcinoma (HCC) located in the hepatic dome cannot
be depicted on ultrasography because of pulmonary air. Therefore, percutaneous treatment …

BACKGROUND AND STUDY AIMS: Biliary stricture after radiofrequency ablation (RFA) for
nodules of hepatocellular carcinoma (HCC) close to major bile ducts sometimes causes …

Purpose We retrospectively evaluated whether combined use of chemoembolization
expands ablative zone sizes created by radiofrequency (RF) ablation in patients with small …

Radiofrequency ablation (RFA) is increasingly being used as percutaneous treatment of
choice for patients with early stage hepatocellular carcinoma (HCC). An accurate …

Background: Radiofrequency ablation (RFA) is a novel thermal ablation technique to
achieve coagulative necrosis of hepatocellular carcinoma. A study was conducted to …

BACKGROUND The therapeutic efficacy of radiofrequency ablation (RFA) for hepatocellular
carcinoma (HCC) is limited by the small volume of coagulation necrosis obtained at each …